2'-hydroxyflavanone has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Izumi, K; Mizokami, A; Nakagawa-Goto, K; Saito, Y; Tsurimoto, H | 1 |
| Goto, M; Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kano, H; Makino, T; Mizokami, A; Naito, R; Nakagawa-Goto, K; Nakata, H; Saito, Y; Shimada, T; Yaegashi, H | 1 |
| Gu, Y; He, D; Huang, J; Hui, K; Ning, Z; Wang, X; Wu, K; Wu, S; Yue, Y | 1 |
| Fan, J; Gao, Y; He, D; Hsieh, JT; Ning, Z; Wang, B; Wang, X; Wu, K; Zhou, J; Zhu, J | 1 |
4 other study(ies) available for 2'-hydroxyflavanone and Cancer of Prostate
| Article | Year |
|---|---|
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2018 |
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Flavanones; Humans; Male; Mice; Mice, SCID; Molecular Structure; PC-3 Cells; Prostatic Neoplasms; Taxoids; Xenograft Model Antitumor Assays | 2021 |
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.
Topics: Apoptosis; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Flavanones; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Wnt Signaling Pathway | 2018 |
2'-hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Flavanones; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor | 2014 |